Search Filters

Search Results

Found 2 results

510(k) Data Aggregation

    K Number
    K221052
    Date Cleared
    2023-09-25

    (532 days)

    Product Code
    Regulation Number
    874.3325
    Reference & Predicate Devices
    Predicate For
    N/A
    Why did this record match?
    Reference Devices :

    K212609

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Self-Fitting hearing aids are intended to amplify sound for individuals 18 years of age or older with to moderate hearing impairment. They are adjusted by the user's hearing needs. The device is intended for use without the assistance of a hearing care professional.

    Device Description

    Per 21 CFR 874.3325, a self-fitting wireless air conduction hearing aid is a wearable sound amplifying device that is intended to compensate for impaired hearing and incorporates technology, including software, that allows users to program their hearing aids. This technology integrates user input with a self-fitting strategy and enables users to independently derive and customize their hearing aid fitting and settings. Self-fitting wireless air conduction hearing aids are Class II medical devices. The Self-Fitting hearing aids incorporate microphones for audio input and sound is delivered to the ear via a receiver that can be coupled with domes. Self-Fitting hearing aids are controlled via button controls and wirelessly via the smart hearing app (iOS and Android). The controls allow the user to adjust volume setting and customize the hearing mode program.

    AI/ML Overview

    Here's an analysis of the acceptance criteria and the study that proves the device meets them, based on the provided text:

    Acceptance Criteria and Device Performance for Self-Fitting Hearing Aids (K221052)

    1. Table of Acceptance Criteria and Reported Device Performance:

    Acceptance Criteria CategorySpecific MetricAcceptance Criteria (Non-Inferiority Margin)Reported Device Performance (Confidence Interval / P-value)
    Co-Primary EndpointsREAG (Self-fit vs. Pro-fit) at 500Hz, 1000Hz, 2000Hz, 4000Hz (Lab)-2.5 dB (non-inferiority margin)- Right Ear: 500Hz: (-1.7976, 0.8933), P<0.0001 1000Hz: (-2.6485, 1.0217), P=0.0005 (Note: Upper bound for 1000Hz is slightly above 2.5, but text states "less than the threshold of 2.5" - this might be due to rounding or a specific interpretation of the non-inferiority test, which relies on the lower bound being above the margin for superiority. The p-value indicates non-inferiority was met.) 2000Hz: (-1.0099, 1.0003), P=<0.0001 4000Hz: (-1.6803, 2.2401), P=0.0139- Left Ear: 500Hz: (-2.4308, 0.5744), P=<0.0001 1000Hz: (-3.9191, 0.6464), P=0.0009 2000Hz: (-4.3019, -0.6981), P=<0.0001 (Negative lower bound suggests superiority of self-fit, still meets non-inferiority) 4000Hz: (-2.3433, 2.3625), P=0.0194Conclusion: Laboratory REAG of Self-fit condition was not inferior to Pro-fit condition with a threshold of 2.5 dB.
    REAG (Self-fit1 vs. Self-fit2) at 500Hz, 1000Hz, 2000Hz, 4000Hz (Lab)Similar (statistical non-significance)- Right Ear: 500Hz: (-1.0725, 0.8725), P=0.8349 1000Hz: (-0.6767, 1.9434), P=0.3310 2000Hz: (-1.9115, 1.1115), P=0.5925 4000Hz: (-1.1188, 1.8522), P=0.6175 - Left Ear: 500Hz: (-1.5968, 1.3302), P=0.8535 1000Hz: (-0.5968, 2.3302), P=0.2356 2000Hz: (-0.4443, 2.1777), P=0.1868 4000Hz: (-1.8498, 1.9831), P=0.9438 Conclusion: No statistically significant difference between the two measurements of REAG for Self-fit repeated measures in the laboratory, indicating similarity.
    APHAB global rating (Self-fit vs. Pro-fit) (Field Trial)-0.084 (non-inferiority margin)Point estimate = 0.0109 (95% CI: -0.00951, 0.0314). All values in the CI are greater than the non-inferiority margin of -0.084. P<0.0001.Conclusion: During the on-site field trial, APHAB global ratings in the Self-fit condition were not inferior to those of the Pro-fit condition with the non-inferiority margin of 0.084.
    Secondary EndpointsSNR (Self-fit vs. Pro-fit) (Lab)Not inferior (no specific margin given)Difference = 0.4450 (95% CI: -0.6703, 1.5602)
    SNR (Self-fit1 vs. Self-fit2) (Lab)Similar (statistical non-significance)Difference = 0.4000 (95% CI: -0.5020, 1.3020)
    SNR (Self-fit vs. Pro-fit) (Field Trial)Not inferior (no specific margin given)Difference = -0.1830 (95% CI: -1.0473, 0.6812)
    Safety EvaluationAbsence of device-related Adverse Events (AE) or Serious Adverse Events (SAE)No AEs or SAEs reportedAll participants were free from ear infections, pain/discomfort, dizziness, and sudden onset/rapid deterioration of tinnitus. No adverse events were reported during the clinical trial.

    2. Sample Sizes and Data Provenance:

    • Clinical Test Set Sample Size: 36 subjects were initially enrolled, but 6 withdrew, resulting in 30 subjects for analysis. The document states the planned minimum was 32 subjects.
    • Data Provenance: The clinical study was a prospective, randomized, cross-assigned, non-inferiority, multi-center clinical trial. The locations of the two on-site centers are implied to be within the country of the submitter (China, Huizhou Jinghao Medical Technology Co., Ltd. and Shenzhen Reanny Medical Devices Management Consulting Co., Ltd.), though not explicitly stated for the subjects' origin.

    3. Number and Qualifications of Experts for Ground Truth:

    • For the Pro-fit condition, which serves as a comparison to the self-fit device, the text refers to "audiological best practice hearing aid fittings." This implies that qualified audiologists or hearing care professionals established the "ground truth" for the professional fitting. The number and specific qualifications of these experts are not explicitly stated in the provided text.

    4. Adjudication Method for the Test Set:

    • The study design was a randomized, cross-assigned, non-inferiority, multi-center clinical trial. Participants underwent two stages: "laboratory" and "on-site cross wear field trial."
    • Within the laboratory stage, participants completed "Self-fit1", "Self-fit2", and "Pro-fit" procedures in random order.
    • The field trial involved a crossover design with participants receiving "Pro-fit" and "Self-fit" in random order.
    • This design inherently compares the different fitting strategies rather than relying on a separate adjudication method for individual cases or outcomes from human readers. The outcomes (REAG, APHAB, SNR) are objective measurements or standardized questionnaires, directly comparing the performance of the self-fitted device to a professionally fitted one. No specific adjudication method like 2+1 or 3+1 is mentioned, as it's not a study involving human reader interpretations that need consensus.

    5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study:

    • No, a Multi-Reader Multi-Case (MRMC) comparative effectiveness study was not conducted in the traditional sense for image interpretation. This study focuses on the comparison between a self-fitting hearing aid and a professionally-fitted hearing aid, not on the performance of human readers with or without AI assistance for interpretation. Therefore, there is no effect size of how much human readers improve with AI vs. without AI assistance.

    6. Standalone (Algorithm Only) Performance Study:

    • Yes, a standalone performance study was conducted in the sense that the "Self-fit" condition represents the algorithm's performance without direct intervention from a hearing care professional during the fitting process by the user. The co-primary and secondary endpoints directly measure the performance of this self-fitting strategy against a professional fitting.

    7. Type of Ground Truth Used:

    • For the clinical study, the "ground truth" or reference for comparison was established by:
      • Audiological Best Practice Hearing Aid Fittings (Pro-fit): This involved a professionally conducted fitting, likely by qualified audiologists, measuring Real Ear Aided Gain (REAG) and collecting data on Abbreviated Profile of Hearing Aid Benefit (APHAB) and Speech Recognition Threshold in Noise (SNR). This serves as the "gold standard" or "expert ground truth" for optimal hearing aid performance.
      • Repeated Self-fitting Measurements (Self-fit1 vs. Self-fit2): This evaluated the consistency and repeatability of the device's self-fitting process, essentially using the device's own repeated output as a comparison for its internal consistency.

    8. Sample Size for the Training Set:

    • The document describes a clinical validation study for effectiveness and safety. It does not explicitly mention a training set sample size for the development of the self-fitting algorithm itself. The clinical study is a test set of real users validating the already developed self-fitting strategy.

    9. How Ground Truth for the Training Set Was Established:

    • Since there's no explicit mention of a training set or its sample size, there's no information provided on how ground truth for a training set was established. The self-fitting strategy is a feature of the device; its development would likely involve internal testing, algorithm design, and potentially proprietary data, but these details are not part of this 510(k) summary which focuses on the clinical validation of the final product.
    Ask a Question

    Ask a specific question about this device

    K Number
    K221064
    Manufacturer
    Date Cleared
    2022-10-30

    (202 days)

    Product Code
    Regulation Number
    874.3325
    Reference & Predicate Devices
    Predicate For
    Why did this record match?
    Reference Devices :

    BHA100 Series Braun® Clear™ Hearing Aid - K212609

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The IQbuds 2 PRO Hearing Aids are intended to amplify sound for individuals 18 years of age or older with perceived mild to moderate hearing impairment. They are adjusted by the user to meet the user's hearing needs. No pre-programming or hearing test is necessary. The device is intended for over the counter sale and use without the assistance of a hearing care professional.

    Device Description

    The Nuheara IQbuds 2 PRO Hearing Aid (Model NU320) is a self-fitting wireless air conduction hearing aid (§ 874.3325) consisting of the hearing aids with Ear Tips. Charge Case, Nuheara software, the Nuheara app, and accessories supplied in the carton. The device is indicated for over-the-counter sale. The hearing aids are designed to be worn in both ears simultaneously with the appropriate size Ear Tips fitted to the sound port of the aid. The device has Ear ID, an innovative hearing assessment system that uses the NAL-NL2 unique programming formula designed for and used globally by hearing aid manufacturers. This hearing profile/personalization system in the IQbuds 2 PRO Hearing Aid assesses the individual's hearing levels across a frequency spectrum to customize the device's amplification specific to their hearing needs. In addition to hearing aid functionality for environmental and directive listening (using the microphones on the aids); the hearing aids can be used for making and receiving phone calls and for streaming audio from a Bluetooth®-compliant mobile device that has been paired with the Nuheara Hearing Aids.

    AI/ML Overview

    Here's a breakdown of the acceptance criteria and the study that proves the Nuheara IQbuds 2 PRO Hearing Aid meets them, based on the provided document:

    The document describes the performance of the Nuheara IQbuds 2 PRO Hearing Aid as part of its 510(k) premarket notification to the FDA, demonstrating its substantial equivalence to predicate devices. The studies primarily focus on usability and clinical performance to show effectiveness and safety.

    1. Table of Acceptance Criteria and Reported Device Performance

    The document doesn't explicitly list "acceptance criteria" in a clean table format with specific numerical targets for usability or clinical performance in the same way it does for electro-acoustic characteristics. Instead, the acceptance criteria for Usability and Clinical Performance appear to be demonstrated by showing that the device is safe and effective for its intended use by the target population and that its performance is comparable to established benchmarks or predicate devices.

    For Electro-Acoustic Characteristics, the acceptance criteria are implicit: the device must meet or be within the established standards (ANSI S3.22 and CTA 2051:2017) and be comparable to the predicate device.

    Implicit Acceptance Criteria and Reported Performance (derived from the text):

    Feature/MetricImplicit Acceptance Criteria / Comparison StandardReported Device Performance/Study Findings
    UsabilityDevice must be safe and effective for intended users to operate without professional assistance, demonstrating that identified use-related risks are mitigated.Demonstrated that the device was safe and effective to operate by the intended user when used in accordance with its intended use. Usability was analyzed, verified, and validated; mitigations for user training and device labeling were adequate. No tasks identified as "critical," 3 deemed "essential" (warnings/cautions from User Guide) which implies these were addressed.
    Clinical Effectiveness (Overall)Device provides clinically meaningful benefit for individuals with perceived mild to moderate hearing impairment, comparable to established fitting algorithms (NAL-NL2) and reference devices/literature.Quantitative Comparison (REIG vs. NAL-NL2): Ear ID™ provides acceptable margins of amplification, within ± 5 dB range, from prescribed targets (NAL-NL2), when averaged across the group. APHAB: Improved mean scores (lower scores) in aided condition for ease of communication in noise (17.8 points), in quiet (7.4 points), and in reverberation (8.2 points). Global improvement of 11 points. Unaided to Aided differences well within published 5-30% percentile norms. Outcomes consistent with studies using NAL-NL2 fit (e.g., Valente et al., 2018; Abrams et al., 2012). SSQ: Results (Speech: 7, Spatial: 7.1, Qualities: 7.2) were comparable to Valente study (Speech: 6.8, Spatial: 7.5, Qualities: 7.9) which used NAL-NL2 fit. Speech in Noise: 86% recall when directionality was employed, improving from 56% unaided or aided without directional microphone.
    Electro-Acoustic Characteristics (examples)Must meet ANSI/ASA S3.22 and CTA 2051:2017 standards, comparable to predicate.Latency: 5ms (Predicate: ≤ 15 ms). Meets requirements, same as predicate. Frequency response: 200Hz - 8000 Hz (Predicate: 200Hz - 8000 Hz). Same as predicate. Input Distortion: ≤ 5% (measured 0.7%) (Predicate: ≤ 5%). Meets requirements, same as predicate. Equivalent Input Noise (EIN): 28.5 dB SPL (Predicate: 26 dB). Meets requirements, same as predicate. Harmonic Distortion: 0.2% (Predicate: ≤ 5%). Meets requirements, same as predicate. Max OSPL90: 109.6 dB SPL (Predicate: 115 dB SPL, Reference: 120 dB SPL). Meets requirements, same as predicate. HFA OSPL90: 100.9 dB SPL (Predicate: 112 dB SPL, Reference: 111 ± 2 dB SPL). Meets requirements, lower than predicate but does not introduce safety questions. HFA FOG: 29.4 dB SPL (Predicate: 43 dB, Reference: 40 ± 2 dB). Meets requirements, lower than predicate but does not introduce safety questions. RTG: 24.4 dB SPL (Predicate: 36 dB, Reference: 34 ± 4 dB). Meets requirements, lower than predicate but does not introduce safety questions.
    BiocompatibilityMust meet ISO 10993 standards and not pose biological risks.Passed all relevant non-clinical performance testing and biological endpoints: cytotoxicity (ISO 10993-05:2009), sensitization, and intracutaneous reactivity (ISO 10993-10:2010).
    Electrical Safety, EMC, Battery Safety, SoftwareMust meet relevant IEC and ISO standards and FDA guidance, mitigating risks to an acceptable level consistent with predicate.Passed all relevant non-clinical performance testing. Software developed, tested, and documented per IEC 62304:2006+A1:2015, FDA guidances (Software Contained in Medical Devices 2005, Cybersecurity in Medical Devices 2018). Demonstrated mitigation of risks to acceptable level and reasonable assurance of safe and effective non-clinical performance, consistent with predicate.

    2. Sample Size Used for the Test Set and Data Provenance

    • Usability Testing:
      • Sample Size: Eighteen (18) adults.
      • Data Provenance: The study was conducted in a "quiet, comfortable room" for one-on-one sessions, implying a controlled, prospective study. The location is not explicitly stated (e.g., country of origin), but the context of an FDA submission for a US market suggests it was likely conducted in the US or in compliance with US regulatory standards.
    • Clinical Performance Study:
      • Sample Size: Forty-three (43) adults.
      • Data Provenance: This was a "prospective investigation." Similar to usability, the exact country is not stated, but it's part of a US FDA submission.

    3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications

    The document does not explicitly state the number or specific qualifications of experts used to establish ground truth for the test set in the same way one might expect for imaging studies.

    • Usability Testing: "An independent, trained moderator conducted each session." It doesn't specify if experts established a 'ground truth' for whether a task was performed correctly beyond the scoring of completion by the moderator and review by a "cross-functional team."
    • Clinical Performance Study:
      • NAL-NL2 Reference: The "audiologist determined REM using standard audiologic practice (NAL-NL2)" serves as a direct ground truth. This implies audiologists were involved.
      • Subjective Questionnaires (APHAB, SSQ): These are self-reported measures, so the "ground truth" is the participant's own perception, not expert-established.
      • Speech in Noise: This involves objective performance (percent recall of sentences) vs. a known noise background.
      • The "Ear ID feature... was developed and validated by National Acoustics Laboratories (NAL)." This indicates expert development of the core self-fitting algorithm.

    No explicit mention of a "number of experts" for adjudication or ground truth per test case.

    4. Adjudication Method for the Test Set

    The document does not describe a formal "adjudication method" like 2+1 or 3+1, which is common in radiologic image interpretation studies.

    • Usability Testing: Participants were "scored on status of completion of all steps in each of the tasks." A "cross-functional team reviewed outcomes at frequent intervals and addressed changes." This implies consensus or review, but not a specific adjudication protocol.
    • Clinical Performance Study: The methods used (comparison to NAL-NL2, self-reported questionnaires, objective speech-in-noise tests) are direct measurements or comparisons against established audiological standards, not subject to typical human reader adjudication.

    5. Multi Reader Multi Case (MRMC) Comparative Effectiveness Study

    No, a multi-reader multi-case (MRMC) comparative effectiveness study was not conducted in the traditional sense of human readers interpreting medical images with and without AI assistance. This device is a self-fitting hearing aid, not an AI for image interpretation.

    The clinical performance study does compare the performance of the device's self-fitting method (Ear ID) to established audiological practices (NAL-NL2) and to the unaided condition, demonstrating clinical effectiveness. This serves a similar purpose of demonstrating effectiveness, but via audiological metrics rather than MRMC.

    • Effect Size (Unaided vs. Aided performance from APHAB):
      • Unaided to Aided difference in mean scores (lower is better):
        • Ease of Communication (EC) in quiet: 7.4 points
        • Reverberation (RV): 8.2 points
        • Background Noise (BN): 17.8 points
        • Global Score: 11 points
      • These improvements were "well within the published 5-30 (%) percentile norms for the APHAB (Cox and Alexander, 1995)." The study also references Valente et al., 2018, which showed a significant median advantage of 4.2% for NAL-NL2 fitted subjects vs. manufacturer default fit for the background noise subscale problem score.

    6. Standalone (Algorithm Only Without Human-in-the-Loop Performance)

    Yes, the "Clinical Performance" study effectively assesses the standalone performance of the device's self-fitting algorithm (Ear ID) by:

    • Quantitatively comparing target gain from the self-fit (Ear ID) to audiologist-determined NAL-NL2 REM targets. This is a direct measure of the algorithm's output against a gold standard.
    • The entire premise of a "self-fitting" hearing aid is that the algorithm (Ear ID) performs the fitting function without professional human intervention in the loop.

    7. The Type of Ground Truth Used

    • Clinical Performance:

      • Expert Consensus/Standard Practice: For the quantitative comparison, the ground truth was "audiologist determined REM using standard audiologic practice (NAL-NL2)." This represents a professional, expert-established standard.
      • User Performance/Subjective Outcomes: For the APHAB and SSQ, the ground truth is the individual participant's self-reported perception of their listening experience and sound quality. For Speech in Noise, it's the objective percentage of recalled sentences.
    • Usability Testing: The ground truth for task completion was based on the success/failure observed by a trained moderator against predefined task steps.

    8. The Sample Size for the Training Set

    The document does not specify a separate "training set" for the device's main self-fitting algorithm. The Ear ID system is described as using a "validated NAL-NL2 fitting algorithm" developed by National Acoustics Laboratories (NAL). NAL-NL2 is a widely recognized and established prescriptive formula for hearing aid fitting, not typically something a new device "trains" on in the machine learning sense. Instead, the device implements this algorithm.

    If there were any machine learning components (e.g., for noise reduction or sound processing features), the training data for those are not disclosed in this document. The focus here is on the validation of the implementation of the NAL-NL2 principle and the device's overall performance.

    9. How the Ground Truth for the Training Set Was Established

    As noted above, there's no explicitly mentioned "training set" for the core self-fitting algorithm (Ear ID) in the machine learning sense that would require a separate ground truth establishment. The Nuheara IQbuds 2 PRO Hearing Aid utilizes the "validated NAL-NL2 fitting algorithm." The ground truth for NAL-NL2 itself (as a prescriptive target based on audiometric data) is an established audiological standard developed through extensive research and clinical validation by the National Acoustics Laboratories.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1